NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Dec 6, 2023 $0.283 -0.70% $0.279 V 98.57% 2
Dec 6, 2023 $0.325 +13.93% $0.279 X 83.62% 0
Dec 6, 2023 $0.349 +22.29% $0.279 X 75.08% 0
JS JS Pro
Dec 5, 2023 $0.338 +5.96% $0.285 X 81.40% 0
Dec 5, 2023 $0.385 +20.77% $0.285 X 64.83% 0
Dec 5, 2023 $0.360 +12.98% $0.285 X 73.54% 0
JS JS Pro
Dec 1, 2023 $0.337 -0.33% $0.325 V 96.31% 1
Dec 1, 2023 $0.413 +22.19% $0.325 X 72.89% 0
Dec 1, 2023 $0.385 +13.87% $0.325 X 81.54% 0
Jul 5, 2023 $4.30 +4.12% $4.33 V 99.31% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE